HP
IDYA icon

HealthInvest Partners’s IDEAYA Biosciences IDYA Stock Holding History

HealthInvest Partners’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.52M Buy
94,478
+63,345
+203% +$1.94M 0.95% 34
2026
Q1 		$4.01M Sell
31,133
-66,305
-68% -$2.22M 1.3% 30
2025
Q4 		$3.37M Buy
+97,438
New +$3.11M 1.07% 30

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

HealthInvest Partners's IDYA Position: Q2 2026 in Review

HealthInvest Partners increased its IDEAYA Biosciences (IDYA) stake by 203% in Q2 2026, buying an estimated $1.94M and bringing the position to 94,478 shares worth $3.52M. The position accounts for 0.95% of the portfolio, ranked #34.

HealthInvest Partners first reported a position in IDYA in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.01M in Q1 2026. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • HealthInvest Partners held 94,478 shares of IDEAYA Biosciences worth $3.52M as of Q2 2026.
  • HealthInvest Partners bought 63,345 IDEAYA Biosciences shares in Q2 2026, an estimated $1.94M.
  • IDEAYA Biosciences made up 0.95% of HealthInvest Partners's portfolio in Q2 2026, its #34 holding.
  • HealthInvest Partners first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 3 quarters since.
  • HealthInvest Partners's IDEAYA Biosciences position peaked at $4.01M in Q1 2026.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.